missing translation for 'onlineSavingsMsg'
Learn More

GPR83 Monoclonal Antibody (OTI6C6), TrueMAB™, OriGene

Mouse Monoclonal Antibody

Brand:  Origene Technologies TA811749

Encompass_Preferred

 View more versions of this product

Product Code. 17565974

  • € 540.87 / 100µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

GPR83, a 423 A.A protein, is an orphan member of GPCR protein family and is closely related to tachykinin and NPY receptors. It is a human homolog of mouse GIR protein and is exclusively expressed and selectively up-regulated in brain. It is a cell surface receptor protein consisting of a putative seven-transmembrane-domain. Reports suggest GPR83 might be involved in the regulation of immune tolerance mechanism by inducing peripheral generation of Foxp3+ Treg cells.
Specifications

Specifications

GPR83
Monoclonal
Unconjugated
Gpr83
GIR, GPR72
Mouse
Affinity Chromatography
RUO
14608
-20° C, Avoid Freeze/Thaw Cycles
Liquid
Western Blot
OTI6C6
PBS with 1% BSA, 50% glycerol and 0.02% sodium azide
P30731
Gpr83
Synthetic peptide
100 μL
Primary
Mouse
Antibody
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.